Young Adult Hypertension Self-Management Clinical Trial (MyHEART)

May 15, 2023 updated by: University of Wisconsin, Madison

The MyHEART Study: A Young Adult Hypertension Self-Management Randomized Controlled Trial

This is a 5-year randomized controlled trial in two large healthcare systems (Madison and Milwaukee, WI) to evaluate MyHEART's (My Hypertension Education And Reaching Target) impact on blood pressure among 310 geographically and racially/ethnically diverse young adults.

Study Overview

Detailed Description

Aim 1. To evaluate the effect of MyHEART (home blood pressure monitor distribution and heath coaching) on clinical outcomes, the change in systolic and diastolic blood pressure (primary) and hypertension control (secondary) after 6 and 12 months, compared to usual clinical care.

Aim 2. To evaluate the effect of MyHEART on hypertension self-management behavior (behavioral outcomes) at 6 and 12 months, compared to usual clinical care.

Aim 3. To examine whether MyHEART's effects on self-management behavior are mediated through variables of perceived competence, autonomy, motivation, and activation (mediation outcomes).

Study Type

Interventional

Enrollment (Actual)

316

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Wisconsin
      • Madison, Wisconsin, United States, 53792
        • University of Wisconsin School of Medicine & Public Health
      • Milwaukee, Wisconsin, United States, 53233
        • Aurora Health Care

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 39 years (Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Willing and capable of giving written informed consent
  • Willing to comply with all study procedures and be available for the duration of the study
  • Males and females ages 18-39 years old at the start of the study (inclusive)
  • A minimum of two hypertension ICD-10 coded visits with a provider (physician [MD, DO], physician assistant, nurse practitioner) on different dates in the last 24 months, with at least one code in the past 18 months
  • Medically homed at an IRB approved healthcare system

Exclusion Criteria:

  • History of medically determined Congestive Heart Failure
  • Unable to provide informed consent (i.e., activated healthcare power of attorney)
  • Unable or unwilling to travel to local clinic for research visits
  • Currently residing in a skilled nursing facility
  • Diagnosed with sickle cell anemia or cystic fibrosis
  • Diagnosed with stroke, myocardial infarction, and/or coronary artery revascularization in the past 2 years
  • Syncope while exercising or doing strenuous activity within past 12 months
  • Currently prescribed warfarin, novel oral anticoagulant, or insulin
  • Planned organ transplant or prior transplant in the past 5 years
  • Chemotherapy or radiation therapy within 6 the past months
  • Severely impaired hearing, vision, or speech, as determined by study staff responsible for enrollment
  • Current participation or planning to participate in another clinical trial in the next 12 months
  • Pregnant or planning to become pregnant in the next 12 months
  • Planning to leave the geographic area in the next 6 months
  • Health condition that will limit both increasing physical activity and changing diet
  • Illegal drug use (other than marijuana) in the past 30 days
  • Unable to read or communicate in English
  • Currently on dialysis or seeing a Nephrologist
  • Unaware or denies history of high blood pressure or hypertension
  • Between-arm blood pressure difference >20 mmHg
  • White Coat Hypertension (24-hour ambulatory monitoring)
  • Inability to comply with or complete the protocol or other reasons at the discretion of the principal and site investigators
  • Prisoners

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention
Telephone health coaching, home blood pressure monitoring, individualized goal setting, and tailored educational materials
Intervention arm participants will receive a home blood pressure monitor, home blood pressure log, and training on accurate home monitoring. They will be asked to share their home blood pressure readings during health coach telephone calls.
Intervention arm participants will receive a health coach phone call every 2 weeks for 6 months, for a total of 12 calls. During each call, the health coach will review and discuss home blood pressures and address barriers and concerns to hypertension management. During each telephone call, the coach will guide the participant on selecting health behavior goals. Intervention arm participants will also receive handouts about hypertension management during the study visits and after health coach calls.
No Intervention: Usual clinical care
Usual care arm participants will receive routine hypertension clinical care per their primary care provider.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
24-hour Systolic Ambulatory Blood Pressure (mmHg)
Time Frame: baseline, 6 month, and 12 month follow-up
24-hour Systolic Ambulatory Blood Pressure measured at baseline, 6 months, and 12 months.
baseline, 6 month, and 12 month follow-up
24-hour Diastolic Ambulatory Blood Pressure (mmHg)
Time Frame: baseline, 6 month, and 12 month follow-up
24-hour Diastolic Ambulatory Blood Pressure measured at baseline, 6 months, and 12 months.
baseline, 6 month, and 12 month follow-up
Clinic Systolic Blood Pressure (mmHg)
Time Frame: baseline, 6 month, and 12 month follow-up
Systolic Blood Pressure measured at baseline, 6 months, and 12 months.
baseline, 6 month, and 12 month follow-up
Clinic Diastolic Blood Pressure (mmHg)
Time Frame: baseline, 6 month, and 12 month follow-up
Clinic Diastolic Blood Pressure measured at baseline, 6 months, and 12 months.
baseline, 6 month, and 12 month follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of Participants That Achieve Hypertension Control at 6 Months
Time Frame: up to 6 months
Hypertension Control: Percentage of participants that achieve hypertension control at 6 months. Hypertension control will be defined using ambulatory blood pressures as the gold standard (<130/80 mmHg); otherwise a clinic blood pressure of <140/90 mmHg will be used.
up to 6 months
Sodium Intake as Assessed by the Automated Self-Administered 24-hour Dietary Assessment
Time Frame: baseline, 6 month, and 12 month follow-up
Mean daily sodium intake (milligrams/day) at baseline, 6 months, and 12 months as assessed by the computer administered Automated Self-Administered 24-hour Dietary Assessment
baseline, 6 month, and 12 month follow-up
Number of Combined Fruit and Vegetable Servings as Assessed by the Automated Self-Administered 24-hour Dietary Assessment
Time Frame: baseline, 6 month, and 12 month follow-up
Mean number of combined fruit and vegetable servings measured at baseline, 6 months, and 12 months as assessed by the computer administered Automated Self-Administered 24-hour Dietary Assessment, reported in cups equivalent.
baseline, 6 month, and 12 month follow-up
Ounces of Whole Grain as Assessed by the Automated Self-Administered 24-hour Dietary Assessment
Time Frame: baseline, 6 month, and 12 month follow-up
Ounces of whole grain measured at baseline, 6 months, and 12 months as assessed by the computer administered Automated Self-Administered 24-hour Dietary Assessment
baseline, 6 month, and 12 month follow-up
Saturated Fat as Assessed by the Automated Self-Administered 24-hour Dietary Assessment
Time Frame: baseline, 6 month, and 12 month follow-up
Saturated fat measured at baseline, 6 months, and 12 months as assessed by the computer administered Automated Self-Administered 24-hour Dietary Assessment, reported in percent kilocalories
baseline, 6 month, and 12 month follow-up
Physical Activity as Assessed by the Godin Physical Activity Questionnaire
Time Frame: baseline, 6 month, and 12 month follow-up

Mean weekly amounts of physical activity as assessed by the Godin Physical Activity Questionnaire. The Godin Physical Activity Questionnaire measures a person's strenuous, moderate, and light physical activity in a week. Scoring is calculated as follows (units are times per week that the participant engaged in any of the 3 classifications of activity longer than 15 minutes during their free time):

  • 9 x strenous units reported + 5 x moderate units reported + 3 x light units reported = score

A minimum score of 0 indicates no activity, a score of less than 14 is interpreted as insufficiently active or sedentary, a score between 14 and 23 is interpreted to be moderately active, and a score of 24 and higher is interpreted to be active, a theoretical maximum does not exist.

baseline, 6 month, and 12 month follow-up
Home Blood Pressure Monitoring Frequency
Time Frame: baseline, 6 month, and 12 month follow-up
Self-report of home blood pressure monitoring frequency measured at baseline, 6 months, and 12 months.
baseline, 6 month, and 12 month follow-up
Standing Weight (kg)
Time Frame: baseline, 6 month, and 12 month follow-up
Weight (kg) measured at baseline, 6 months, and 12 months.
baseline, 6 month, and 12 month follow-up
Perceived Competence as Assessed by the Perceived Competence Scale for Diet
Time Frame: baseline, 6 month, and 12 month follow-up
Perceived competence measured at baseline, 6 months, and 12 months as assessed by the Perceived Competence Scale (self-administration). This is a 4-item survey scored on a 7 point likert scale from 1 (not at all true) to 7 (very true). Mean score from 1-7 will be reported with higher scores indicating increased perceived competence.
baseline, 6 month, and 12 month follow-up
Perceived Competence as Assessed by the Perceived Competence Scale for Exercise
Time Frame: baseline, 6 month, and 12 month follow-up
Perceived competence measured at baseline, 6 months, and 12 months as assessed by the Perceived Competence Scale (self-administration). This is a 4-item survey scored on a 7 point likert scale from 1 (not at all true) to 7 (very true). Mean score from 1-7 will be reported with higher scores indicating increased perceived competence.
baseline, 6 month, and 12 month follow-up
Perceived Autonomy as Assessed by the Health Care Climate Questionnaire for Diet
Time Frame: baseline, 6 month, and 12 month follow-up
Perceived autonomy measured at baseline, 6 months, and 12 months as assessed by the Health Care Climate Questionnaire (self-administration). This is a 6-item survey scored on a 7 point likert scale from 1 (not at all true) to 7 (very true). Mean between 1-7 will be reported with higher scores indicative of increased perceived autonomy.
baseline, 6 month, and 12 month follow-up
Perceived Autonomy as Assessed by the Health Care Climate Questionnaire for Exercise
Time Frame: baseline, 6 month, and 12 month follow-up
Perceived autonomy measured at baseline, 6 months, and 12 months as assessed by the Health Care Climate Questionnaire (self-administration). This is a 6-item survey scored on a 7 point likert scale from 1 (not at all true) to 7 (very true). Mean between 1-7 will be reported with higher scores indicative of increased perceived autonomy.
baseline, 6 month, and 12 month follow-up
Autonomous Motivation as Assessed by the Treatment Self-Regulation Questionnaire for Diet
Time Frame: baseline, 6 month, and 12 month follow-up
Autonomous motivation measured at baseline, 6 months, and 12 months as assessed by the Treatment Self-Regulation Questionnaire (self-administration). This is a 15-item survey scored on a 7 point likert scale from 1 (not at all true) to 7 (very true). Mean score between 1 and 7 will be reported with higher scores indicative of increased autonomous motivation.
baseline, 6 month, and 12 month follow-up
Autonomous Motivation as Assessed by the Treatment Self-Regulation Questionnaire for Exercise
Time Frame: baseline, 6 month, and 12 month follow-up
Autonomous motivation measured at baseline, 6 months, and 12 months as assessed by the Treatment Self-Regulation Questionnaire (self-administration). This is a 15-item survey scored on a 7 point likert scale from 1 (not at all true) to 7 (very true). Mean score between 1 and 7 will be reported with higher scores indicative of increased autonomous motivation.
baseline, 6 month, and 12 month follow-up
Controlled Motivation as Assessed by the Treatment Self-Regulation Questionnaire for Diet
Time Frame: baseline, 6 month, and 12 month follow-up
Controlled motivation measured at baseline, 6 months, and 12 months as assessed by the Treatment Self-Regulation Questionnaire (self-administration). This is a 15-item survey scored on a 7 point likert scale from 1 (not at all true) to 7 (very true). Mean score between 1 and 7 will be reported with higher scores indicative of increased controlled motivation.
baseline, 6 month, and 12 month follow-up
Controlled Motivation as Assessed by the Treatment Self-Regulation Questionnaire for Exercise
Time Frame: baseline, 6 month, and 12 month follow-up
Controlled motivation measured at baseline, 6 months, and 12 months as assessed by the Treatment Self-Regulation Questionnaire (self-administration). This is a 15-item survey scored on a 7 point likert scale from 1 (not at all true) to 7 (very true). Mean score between 1 and 7 will be reported with higher scores indicative of increased controlled motivation.
baseline, 6 month, and 12 month follow-up
Amotivation as Assessed by the Treatment Self-Regulation Questionnaire for Diet
Time Frame: baseline, 6 month, and 12 month follow-up
Amotivation measured at baseline, 6 months, and 12 months as assessed by the Treatment Self-Regulation Questionnaire (self-administration). This is a 15-item survey scored on a 7 point likert scale from 1 (not at all true) to 7 (very true). Mean score between 1 and 7 will be reported with higher scores indicative of increased amotivation.
baseline, 6 month, and 12 month follow-up
Amotivation as Assessed by the Treatment Self-Regulation Questionnaire for Exercise
Time Frame: baseline, 6 month, and 12 month follow-up
Amotivation measured at baseline, 6 months, and 12 months as assessed by the Treatment Self-Regulation Questionnaire (self-administration). This is a 15-item survey scored on a 7 point likert scale from 1 (not at all true) to 7 (very true). Mean score between 1 and 7 will be reported with higher scores indicative of increased amotivation.
baseline, 6 month, and 12 month follow-up

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Health Coach Fidelity to the Study Intervention
Time Frame: through completion of administering the study intervention, an average of 4 years
Evaluation of health coach fidelity to administering the motivational interviewing intervention per protocol will be assessed every 2 months using a modified Behavior Change Counseling Index
through completion of administering the study intervention, an average of 4 years
Adverse Events
Time Frame: Through study completion, an average of 5 years
Number and type of adverse events
Through study completion, an average of 5 years
Serious Adverse Events
Time Frame: Through study completion, an average of 5 years
Number and type of serious adverse events
Through study completion, an average of 5 years
Withdrawal
Time Frame: Through study completion, an average of 5 years
Subject Withdrawal Rate
Through study completion, an average of 5 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Kara Hoppe, DO, University of Wisconsin, Madison

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 2, 2017

Primary Completion (Actual)

January 13, 2022

Study Completion (Actual)

February 8, 2022

Study Registration Dates

First Submitted

May 15, 2017

First Submitted That Met QC Criteria

May 16, 2017

First Posted (Actual)

May 17, 2017

Study Record Updates

Last Update Posted (Actual)

May 17, 2023

Last Update Submitted That Met QC Criteria

May 15, 2023

Last Verified

May 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2017-0372
  • A534225 (Other Identifier: UW Madison)
  • SMPH\MEDICINE\CARDIOLOGY (Other Identifier: UW Madison)
  • R01HL132148 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hypertension

Clinical Trials on Home Blood Pressure Monitoring

3
Subscribe